TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -5 | -1 | -10 | -31 | -55 | -17 | -20 |
| S | %wins | 100 | 50 | 100 | 100 | 100 | 100 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/18 16:16 | 3/6/18 | EGRX | Eagle Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Flaum Sander A | NJ | D | S.d | -126 | 53.94 | 0 | -2 | -17 | 11 | D | |||||||||||||||
11/30/16 17:12 | 11/28/16 | EGRX | Eagle Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Flaum Sander A | NJ | D | S | -393 | 78.66 | 33 | -5 | -31 | 11 | D | 520 | -15 | 60 | 28 | 20 | 7 | 0 | -2 | -6 | 1 | 0 | -5 | |||
12/23/15 16:47 | 3/20/15 | EGRX | Eagle Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Flaum Sander A | NJ | D | S.m | -714 | 54.81 | 33 | -13 | -44 | 16 | D | 595 | 8 | 9 | 23 | 8 | 3 | -3 | -4 | -2 | -19 | -56 | -55 | -17 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |